New search | Conferencedetail
mail
Print view
 
 

Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
14.12.2021 - 15.12.2021  Online
Time: 8:30 am - 6:15 pm
 
Conference themes
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community.

The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/867375-3?pid=4832

Speakers: Allyson Berent Chief Operating Officer | FAST GeneTx | Biotherapeutics Chief Scientific Officer, Anish Bhatnagar Chief Executive Officer Soleno Therapeutics and more
 

Enquiries and Registration:

https://go.evvnt.com/867375-2?pid=4832
Ms. Stephanie Nketia
 
Categories
General Medicine
Languages
English
Congress fees
Conference Only - Drug Developer: USD 2099.00, Conference Only - Academic: USD 1899.00, Conference Only - Service Provider: USD 2599.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationnewTreeHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrztekammer für WienÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Gesellschaft für Public Health